What is Rhythm Pharmaceuticals, Inc.'s total revenue?

Rhythm Pharmaceuticals, Inc. (RYTM) reported total revenue of $60.11M in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s total revenue changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s total revenue increased by 83.8% year-over-year, from $32.7M to $60.11M.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total revenue?

Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s total revenue has grown at a 178.5% compound annual growth rate (CAGR), from $3.15M to $189.76M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Rhythm Pharmaceuticals, Inc. RYTM Total Revenue

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

Arrowhead ResearchARWR

$73.74M-86.4%

AlkermesALKS

$392.91M+28.2%

BridgeBio PharmaBBIO

$194.52M+66.8%

TG TherapeuticsTGTX

$204.92M+69.6%

Mirum Pharmaceuticals, Inc.MIRM

——

Segments

By segment

See full

Single reportable segment$60.11M+83.8%

By product

See full

License revenue$0+100%

Other financials

Income statement

See full

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s total revenue?: Rhythm Pharmaceuticals, Inc. (RYTM) reported total revenue of $60.11M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s total revenue changed year-over-year?: Rhythm Pharmaceuticals, Inc.'s total revenue increased by 83.8% year-over-year, from $32.7M to $60.11M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total revenue?: Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s total revenue has grown at a 178.5% compound annual growth rate (CAGR), from $3.15M to $189.76M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.